pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-3678 |
Genomic Coordinates | chr17: 75406069 - 75406162 |
Description | Homo sapiens miR-3678 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-3678-3p | ||||||||||||||||||||||||||||||
Sequence | 69| CUGCAGAGUUUGUACGGACCGG |90 | ||||||||||||||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||||||||||||||
Experiments | Illumina | ||||||||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | PPTC7 | ||||||||||||||||||||
Synonyms | TA-PP2C, TAPP2C | ||||||||||||||||||||
Description | PTC7 protein phosphatase homolog | ||||||||||||||||||||
Transcript | NM_139283 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on PPTC7 | |||||||||||||||||||||
3'UTR of PPTC7 (miRNA target sites are highlighted) |
>PPTC7|NM_139283|3'UTR 1 CTGAGGTGTCAAGTCCTGCCTTTCCTTTCATCATCCCAAATTTCCCCTGCCATGTGTGCTGATCCTGCTGGCAGGACCAC 81 ATTTCTTTGCCACTGATCTCAATGGCCAGTGATGTAAGTCTTTTGCCTGTCTTCTTGAGACTCGTTGAGATCTTTGTTGA 161 GAACCACTACTATCATTCACTAGCTCATATCTGCCGGCAGCAATTGAAGAGATCCAATATTTGAAGATTGGCCTTCATTT 241 CTCGATGTTCTTTCCATGATGGGGATGGAGGTGTTCAGTGCCACCGTGGCTGTTACTTTTCAAAGTAGTTGAAGTATTGA 321 AAATGAGTAATGTTGGTAAAGTGAATTCAAAATCCTAGTATGCTAAAGGGATGGTACAAGTCTAACACAAATTGTACGTA 401 ATGATACATCTACTAGAAACATACATTATTCATCAAAAGAAATGTTACATGTGTACTCCACAGGCATAGTCTTTGTTATG 481 ATGATTGGTGTGGCTTTATGTCTTTGTTATAAACTCCTATTTTTCAGGGGCTTATGATTCTGCTCTAAAACATTGCTCTG 561 GGTTATACAGTTTTGATCCCAAAAGCTTTTTTGTTACAAATCGGGAGAAAAATCCATTTTAGTTCTATGGATGGAAATAT 641 TTCATGCTTTTAAAAAGATGTTTGTGTTCCTGTGGTTAAAGTTTTGGCAGTTTATTGATTAGTCCAAATCACAGGCTAAG 721 GCCTGATCTCCAGGAGGGGTAGGGGAGACACTTTACCAGTATTTTTTTATGGAAATAATACTCAAGGTTGTAAAACCCCT 801 CAAAGCCTAGAAATTTAATTGTTATGGCTGAAATTCCTCCTAGTTGTCTGATAGAATGCCCCTGAATGGGAACTCTAGGT 881 CCCAAGGCCTGAAGGGTTGAGAACAGACAGCTGTAACTTTGAATTTTGTTGGCTTTCAGTGGTCATGCTACCTACCCATA 961 CTCGTACTCTCAGACCTTTTATTAGTAGCCTTGCTTTCTATAGAGCATGCACCAAATCCAGTGAGTCCATGTGGAGAGAG 1041 CACTGTGTGCGCAGCGGCAGCAGCACAGACGTCCATGAGGAAAACTCCCAGTGATGATCTGACATTTACAATTACCCCAC 1121 ATGGAAATTTAGGGGTTTCTGAATCAAGCTTAATGTTTACAGTTTCCAAATAGCCATTTTGCAGTGTATAGTTTCCTTAC 1201 AAAACTACCCCGCATTCAGTTTTCACATTATCTGCAAGCTGAAACTTATTTTTAAGTTTTGTGTACAAGTTGACTGCTGT 1281 AAAGATATATATTTTTGGGTCAGTTTTTTTCCTTCATTAACTTGGTGGTAGAAAAAAATATATACTTAGAAATCCTTAAA 1361 TTAAAGCCATGTTTTATATATAAGTCAGGTAACATTGGTGTATAGATGAGAATGCAATTAAACCTGATGAGAATCTACTT 1441 GAGAATATAGAAAGTCTTTCTCTAAAGGAGATACTGACTCCCTGGTTTATTGCATTAAAATTTATGTTTGAGGTTACCTC 1521 AACTTGTTTTAAAAGATTTTGTTTTGTGAATTTGTACTGTATATTTGAGTAACTGTCAGGCTTTTATTTAAAATTGTTTA 1601 ACATGTACCATGTACATGTCATTACTATATTTCAATGCATCATGCTTGTAACAGGCATTTCATTTATAATAAGAATGAGT 1681 TATTCATTTGTAAGCCGTTCAGTAATTTATCTACTATTCCTAAATTGGCATAATGTTAGATAATCTATTTTGAATCACCT 1761 TTAATTACATGTCAGAATGCCTTAACTACCCTAACTTGACAAAACAGAATTCTTTGGTAGACGCGGTGGGGGCGGGGTGG 1841 GGGGTCTGGACGGAGTCTCTATTTAAGGAGAAATCATCATGCTATGATAAAACACAGAAGCATGAGTGGCAAGTGGCGGG 1921 GTATTTATTTTGCACAAACTATTTGCAGTCTCTGTGTATTTAAAAAGTAAAGAAAGTTGCATCCAGAAGGGTTTTGTTAG 2001 AATGAATACATTTATATTAGGACTGACAACTTCAGCTCTTTTGTTTAGGTTTTCAATTATTTTTGGTAAGAGTATGTAGC 2081 CTTATGATCTGGATATATTTTGCATTCATTTTCCAACGCCTACATTTAATTCCTGGTAAGAGCAGTGCTCGTCAAGTTTC 2161 TGGTTTTTCTCTGCTCTCATTTAACCCGTCAAACACAATCTTTGTAAAGCTAGATTGGTGGTGTTTTATACAACTTATTT 2241 ACTCAGCTTACCTTTTTGAGAAACGATTGTTAGAAATTGACGATGTGTTTGTTCCAGTGATACTGAAAGTAGTGGGGGCA 2321 AGAATTGAGTTTCACAGTGGAATTGGCTTTGGATCTGGCCTATAGATTAGTGACATAAAATATTTTCTCTATTTTCCCCT 2401 GTTCTTTTTGTGTTATGCACTTAATTTTATGACTGCCGGGGGGGTCAGCTGGAGTGCTGCTTAACAAGTATCTCTCCTAC 2481 TCTCAGTGGTCAGAGGCTGTGTTGGACCCATAGTAGAATTTTCCAGGTCACAGACCCAAGCTTCCATGGGTTGTTACTGT 2561 GCTGTACCACTTGGTGGGTCTGATTCTGAACCTGATGTGTGTGTT Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | TZM-bl | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
CLIP-seq Support 1 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000354300.3 | 3UTR | UCCUUACAAAACUACCCCGCAUUCAGUUUUCACAUUAUCUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
86 hsa-miR-3678-3p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT074327 | TNRC6A | trinucleotide repeat containing 6A | 2 | 10 | ||||||||
MIRT107705 | CLTA | clathrin light chain A | 2 | 2 | ||||||||
MIRT114113 | AGO1 | argonaute 1, RISC catalytic component | 2 | 2 | ||||||||
MIRT155293 | IFNAR2 | interferon alpha and beta receptor subunit 2 | 2 | 4 | ||||||||
MIRT159171 | NRBP1 | nuclear receptor binding protein 1 | 2 | 2 | ||||||||
MIRT185795 | ZNF678 | zinc finger protein 678 | 2 | 2 | ||||||||
MIRT282672 | SYNM | synemin | 2 | 2 | ||||||||
MIRT294386 | ZNF264 | zinc finger protein 264 | 2 | 2 | ||||||||
MIRT295818 | CHMP4B | charged multivesicular body protein 4B | 2 | 2 | ||||||||
MIRT332777 | CAPRIN1 | cell cycle associated protein 1 | 2 | 4 | ||||||||
MIRT334112 | PPP6R3 | protein phosphatase 6 regulatory subunit 3 | 2 | 2 | ||||||||
MIRT340971 | IPO5 | importin 5 | 2 | 2 | ||||||||
MIRT354679 | CDV3 | CDV3 homolog | 2 | 2 | ||||||||
MIRT366662 | PLP2 | proteolipid protein 2 | 2 | 2 | ||||||||
MIRT404272 | PLEKHA8 | pleckstrin homology domain containing A8 | 2 | 2 | ||||||||
MIRT447536 | RNF165 | ring finger protein 165 | 2 | 2 | ||||||||
MIRT449139 | UQCRB | ubiquinol-cytochrome c reductase binding protein | 2 | 2 | ||||||||
MIRT451301 | LGALS3BP | galectin 3 binding protein | 2 | 2 | ||||||||
MIRT451488 | FOPNL | FGFR1OP N-terminal like | 2 | 2 | ||||||||
MIRT455198 | GNL1 | G protein nucleolar 1 (putative) | 2 | 2 | ||||||||
MIRT459215 | MRPS21 | mitochondrial ribosomal protein S21 | 2 | 2 | ||||||||
MIRT461764 | MPDU1 | mannose-P-dolichol utilization defect 1 | 2 | 2 | ||||||||
MIRT463273 | ZFX | zinc finger protein, X-linked | 2 | 2 | ||||||||
MIRT464862 | UBB | ubiquitin B | 2 | 8 | ||||||||
MIRT464950 | TWIST1 | twist family bHLH transcription factor 1 | 2 | 2 | ||||||||
MIRT467378 | SON | SON DNA binding protein | 2 | 4 | ||||||||
MIRT469282 | RHOA | ras homolog family member A | 2 | 2 | ||||||||
MIRT470293 | PPTC7 | PTC7 protein phosphatase homolog | 2 | 2 | ||||||||
MIRT470639 | POM121C | POM121 transmembrane nucleoporin C | 2 | 2 | ||||||||
MIRT477163 | FABP3 | fatty acid binding protein 3 | 2 | 2 | ||||||||
MIRT477686 | EFHD2 | EF-hand domain family member D2 | 2 | 2 | ||||||||
MIRT479725 | CCNF | cyclin F | 2 | 2 | ||||||||
MIRT481726 | APH1A | aph-1 homolog A, gamma-secretase subunit | 2 | 2 | ||||||||
MIRT485673 | CCDC64 | BICD family like cargo adaptor 1 | 2 | 2 | ||||||||
MIRT498280 | PADI2 | peptidyl arginine deiminase 2 | 2 | 2 | ||||||||
MIRT499921 | GPX8 | glutathione peroxidase 8 (putative) | 2 | 2 | ||||||||
MIRT503616 | SLC25A36 | solute carrier family 25 member 36 | 2 | 4 | ||||||||
MIRT506927 | IGDCC4 | immunoglobulin superfamily DCC subclass member 4 | 2 | 6 | ||||||||
MIRT507348 | FAM129A | family with sequence similarity 129 member A | 2 | 6 | ||||||||
MIRT508265 | DYNLL2 | dynein light chain LC8-type 2 | 2 | 4 | ||||||||
MIRT508284 | YES1 | YES proto-oncogene 1, Src family tyrosine kinase | 2 | 4 | ||||||||
MIRT509353 | COPS8 | COP9 signalosome subunit 8 | 2 | 2 | ||||||||
MIRT510892 | RAB1A | RAB1A, member RAS oncogene family | 2 | 4 | ||||||||
MIRT511882 | GAS1 | growth arrest specific 1 | 2 | 6 | ||||||||
MIRT511990 | E2F1 | E2F transcription factor 1 | 2 | 4 | ||||||||
MIRT512239 | ARPP19 | cAMP regulated phosphoprotein 19 | 2 | 4 | ||||||||
MIRT512392 | BUB1 | BUB1 mitotic checkpoint serine/threonine kinase | 2 | 4 | ||||||||
MIRT514086 | EPS15L1 | epidermal growth factor receptor pathway substrate 15 like 1 | 2 | 6 | ||||||||
MIRT514358 | UBBP4 | ubiquitin B pseudogene 4 | 2 | 6 | ||||||||
MIRT523149 | HNRNPU | heterogeneous nuclear ribonucleoprotein U | 2 | 2 | ||||||||
MIRT525511 | FSIP2 | fibrous sheath interacting protein 2 | 2 | 2 | ||||||||
MIRT526333 | SH3TC2 | SH3 domain and tetratricopeptide repeats 2 | 2 | 2 | ||||||||
MIRT529962 | ZNF71 | zinc finger protein 71 | 2 | 2 | ||||||||
MIRT530337 | GABRB3 | gamma-aminobutyric acid type A receptor beta3 subunit | 2 | 2 | ||||||||
MIRT530884 | PHOX2A | paired like homeobox 2a | 2 | 2 | ||||||||
MIRT533097 | YOD1 | YOD1 deubiquitinase | 2 | 2 | ||||||||
MIRT533250 | VCAM1 | vascular cell adhesion molecule 1 | 2 | 2 | ||||||||
MIRT534786 | RAB8B | RAB8B, member RAS oncogene family | 2 | 2 | ||||||||
MIRT537917 | DSTYK | dual serine/threonine and tyrosine protein kinase | 2 | 2 | ||||||||
MIRT547799 | JARID2 | jumonji and AT-rich interaction domain containing 2 | 2 | 2 | ||||||||
MIRT548714 | CRK | CRK proto-oncogene, adaptor protein | 2 | 2 | ||||||||
MIRT555509 | PMEPA1 | prostate transmembrane protein, androgen induced 1 | 2 | 2 | ||||||||
MIRT555984 | NFYB | nuclear transcription factor Y subunit beta | 2 | 2 | ||||||||
MIRT557942 | FAM222B | family with sequence similarity 222 member B | 2 | 2 | ||||||||
MIRT560830 | ZNF786 | zinc finger protein 786 | 2 | 2 | ||||||||
MIRT562720 | ZNF714 | zinc finger protein 714 | 2 | 2 | ||||||||
MIRT565337 | TMEM104 | transmembrane protein 104 | 2 | 2 | ||||||||
MIRT614453 | REL | REL proto-oncogene, NF-kB subunit | 2 | 2 | ||||||||
MIRT639474 | SLC6A4 | solute carrier family 6 member 4 | 2 | 2 | ||||||||
MIRT644056 | IQCE | IQ motif containing E | 2 | 2 | ||||||||
MIRT651652 | VWA1 | von Willebrand factor A domain containing 1 | 2 | 2 | ||||||||
MIRT651866 | UNC119B | unc-119 lipid binding chaperone B | 2 | 2 | ||||||||
MIRT653490 | SLC43A2 | solute carrier family 43 member 2 | 2 | 2 | ||||||||
MIRT657039 | KCNJ6 | potassium voltage-gated channel subfamily J member 6 | 2 | 2 | ||||||||
MIRT657985 | GAN | gigaxonin | 2 | 2 | ||||||||
MIRT672117 | ATP6V0A2 | ATPase H+ transporting V0 subunit a2 | 2 | 2 | ||||||||
MIRT683583 | GSTCD | glutathione S-transferase C-terminal domain containing | 2 | 2 | ||||||||
MIRT688689 | CPS1 | carbamoyl-phosphate synthase 1 | 2 | 2 | ||||||||
MIRT695375 | NSA2 | NSA2, ribosome biogenesis homolog | 2 | 2 | ||||||||
MIRT696351 | EIF2S3 | eukaryotic translation initiation factor 2 subunit gamma | 2 | 2 | ||||||||
MIRT700614 | PRKAA2 | protein kinase AMP-activated catalytic subunit alpha 2 | 2 | 2 | ||||||||
MIRT703512 | FKBP15 | FK506 binding protein 15 | 2 | 2 | ||||||||
MIRT705051 | C5orf15 | chromosome 5 open reading frame 15 | 2 | 2 | ||||||||
MIRT705180 | BTG1 | BTG anti-proliferation factor 1 | 2 | 2 | ||||||||
MIRT709409 | FBXL20 | F-box and leucine rich repeat protein 20 | 2 | 2 | ||||||||
MIRT721053 | DCC | DCC netrin 1 receptor | 2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|